<p>美國股指期貨今晨走低，道瓊斯期貨週一下跌約 100 點。</p>
<p><strong>Ultragenyx Pharmaceutical Inc</strong>. RARE 的股票在盤前交易中大幅下跌。</p>
<p>Ultragenyx 收到了 FDA 針對 UX111 AAV 基因療法治療 A 型聖菲利波綜合症（MPS IIIA）的完整回應函。</p>
<p>Ultragenyx Pharmaceutical 的股票在盤前交易中下跌 8%，至 27.15 美元。</p>
<h3>熱門投資機會</h3>
<p>以下是一些在盤前交易中下跌的其他股票。</p>
<ul>
<li><strong>MiNK Therapeutics, Inc</strong>. INKT 的股票在盤前交易中暴跌 31%，至 44.25 美元。MiNK Therapeutics 的股票在週五因公司宣佈在《Oncogene》上發表文章而上漲 730%。</li>
<li><strong>Above Food Ingredients Inc</strong>. ABVE 的股票在盤前交易中下跌 21.3%，至 2.84 美元，此前在週五上漲 134%。Above Food Ingredients 最近宣佈與 Palm Global 達成合並協議。</li>
<li><strong>Newegg Commerce, Inc</strong>. NEGG 的股票在盤前交易中下跌 11.3%，至 43.66 美元，此前在週五上漲 71%。</li>
<li><strong>CEL-SCI Corporation</strong> CVM 的股票在盤前交易中下跌 11%，至 3.08 美元，此前在週五下跌 8%。CEL-SCI 最近宣佈與一家沙特阿拉伯製藥和醫療公司簽署了合作協議。</li>
<li><strong>Unusual Machines, Inc</strong>. UMAC 的股票在盤前交易中下跌 8%，至 11.13 美元，此前在週五上漲 39%。</li>
<li><strong>Gossamer Bio, Inc.</strong> GOSS 的股票在盤前交易中下跌 6.6%，至 1.2700 美元。Gossamer Bio 上個月完成了其註冊性 3 期 PROSERA 研究的入組，研究對象為肺動脈高壓。</li>
<li><strong>Gilat Satellite Networks Ltd</strong>. GILT 的股票在盤前交易中下跌 4.1%，至 7.22 美元。Gilat Satellite Networks 最近宣佈其商業部門從衞星運營商那裏獲得了超過 2200 萬美元的訂單。</li>
<li><strong>KalVista Pharmaceuticals, Inc</strong>. KALV 的股票在盤前交易中下跌 4%，至 13.94 美元，此前在週五下跌 6%。KalVista Pharma 最近公佈的季度虧損超出預期。</li>
<li><strong>Apple Inc.</strong> AAPL 的股票在盤前交易中下跌 1%，至 209.22 美元。蘋果公司正在進行重大管理重組。儘管公司面臨多年來最大的危機，首席執行官蒂姆·庫克仍然堅定掌舵。</li>
</ul>
<p><strong>現在閲讀這個：</strong></p>
<ul>
<li><strong>本月可能會崩盤的前三隻房地產股票</strong></li>
</ul>
<p>照片來源於 Shutterstock</p>

蘋果

Ultragenyx制藥

<p>美國股指期貨今晨下跌，道瓊斯期貨下跌約 100 點。Ultragenyx 製藥公司股價下跌 8%，至 27.15 美元，此前其基因療法收到了 FDA 的完整回應函。其他顯著下跌的股票包括 MiNK Therapeutics 下跌 31%，Above Food Ingredients 下跌 21.3%，Newegg Commerce 下跌 11.3%。蘋果公司股價因管理層重組下跌 1%。總體來看，幾隻股票在近期上漲後出現顯著的盤前虧損</p>

<p>U.S. stock futures were lower this morning, with the Dow futures falling around 100 points on Monday.</p>
<div class="lb-trans"><p>美國股指期貨今晨走低，道瓊斯期貨週一下跌約 100 點。</p>
</div><p>Shares of <strong>Ultragenyx Pharmaceutical Inc</strong>. RARE fell sharply in pre-market trading.</p>
<div class="lb-trans"><p><strong>Ultragenyx Pharmaceutical Inc</strong>. RARE 的股票在盤前交易中大幅下跌。</p>
</div><p>Ultragenyx received a Complete Response Letter from the FDA for UX111 AAV gene therapy to treat Sanfilippo Syndrome Type A (MPS IIIA).</p>
<div class="lb-trans"><p>Ultragenyx 收到了 FDA 針對 UX111 AAV 基因療法治療 A 型聖菲利波綜合症（MPS IIIA）的完整回應函。</p>
</div><p>Ultragenyx Pharmaceutical shares dipped 8% to $27.15 in the pre-market trading session.</p>
<div class="lb-trans"><p>Ultragenyx Pharmaceutical 的股票在盤前交易中下跌 8%，至 27.15 美元。</p>
</div><h3>Trending Investment Opportunities</h3>
<div class="lb-trans"><h3>熱門投資機會</h3>
</div><p>Here are some other stocks moving lower in pre-market trading.</p>
<div class="lb-trans"><p>以下是一些在盤前交易中下跌的其他股票。</p>
</div><ul>
<li><strong>MiNK Therapeutics, Inc</strong>. INKT shares tumbled 31% to $44.25 in pre-market trading. MiNK Therapeutics shares jumped 730% on Friday after the company announced a publication in Oncogene.</li>
<li><strong>Above Food Ingredients Inc</strong>. ABVE shares dipped 21.3% to $2.84 in pre-market trading after jumping 134% on Friday. Above Food Ingredients recently announced a merger agreement with Palm Global.</li>
<li><strong>Newegg Commerce, Inc</strong>. NEGG declined 11.3% to $43.66 in pre-market trading after gaining 71% on Friday.</li>
<li><strong>CEL-SCI Corporation</strong> CVM shares dipped 11% to $3.08 in pre-market trading after declining 8% on Friday. CEL-SCI recently announced it signed a partnership with a Saudi Arabian pharma and healthcare company.</li>
<li><strong>Unusual Machines, Inc</strong>. UMAC slipped 8% to $11.13 in pre-market trading after gaining 39% on Friday.</li>
<li><strong>Gossamer Bio, Inc.</strong> GOSS declined 6.6% to $1.2700 in pre-market trading. Gossamer Bio, last month, completed enrollment in its registrational Phase 3 PROSERA study for pulmonary arterial hypertension</li>
<li><strong>Gilat Satellite Networks Ltd</strong>. GILT fell 4.1% to $7.22 in pre-market trading. Gilat Satellite Networks recently announced its commercial division received over $22 million in orders from satellite operators.</li>
<li><strong>KalVista Pharmaceuticals, Inc</strong>. KALV dipped 4% to $13.94 in pre-market trading after falling 6% on Friday. KalVista Pharma recently posted a wider-than-expected quarterly loss.</li>
<li><strong>Apple Inc.</strong> AAPL fell 1% to $209.22 in pre-market trading. Apple is in the midst of a significant management reshuffle. Despite the company's biggest crisis in years, CEO Tim Cook remains firmly at the helm.</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>MiNK Therapeutics, Inc</strong>. INKT 的股票在盤前交易中暴跌 31%，至 44.25 美元。MiNK Therapeutics 的股票在週五因公司宣佈在《Oncogene》上發表文章而上漲 730%。</li>
<li><strong>Above Food Ingredients Inc</strong>. ABVE 的股票在盤前交易中下跌 21.3%，至 2.84 美元，此前在週五上漲 134%。Above Food Ingredients 最近宣佈與 Palm Global 達成合並協議。</li>
<li><strong>Newegg Commerce, Inc</strong>. NEGG 的股票在盤前交易中下跌 11.3%，至 43.66 美元，此前在週五上漲 71%。</li>
<li><strong>CEL-SCI Corporation</strong> CVM 的股票在盤前交易中下跌 11%，至 3.08 美元，此前在週五下跌 8%。CEL-SCI 最近宣佈與一家沙特阿拉伯製藥和醫療公司簽署了合作協議。</li>
<li><strong>Unusual Machines, Inc</strong>. UMAC 的股票在盤前交易中下跌 8%，至 11.13 美元，此前在週五上漲 39%。</li>
<li><strong>Gossamer Bio, Inc.</strong> GOSS 的股票在盤前交易中下跌 6.6%，至 1.2700 美元。Gossamer Bio 上個月完成了其註冊性 3 期 PROSERA 研究的入組，研究對象為肺動脈高壓。</li>
<li><strong>Gilat Satellite Networks Ltd</strong>. GILT 的股票在盤前交易中下跌 4.1%，至 7.22 美元。Gilat Satellite Networks 最近宣佈其商業部門從衞星運營商那裏獲得了超過 2200 萬美元的訂單。</li>
<li><strong>KalVista Pharmaceuticals, Inc</strong>. KALV 的股票在盤前交易中下跌 4%，至 13.94 美元，此前在週五下跌 6%。KalVista Pharma 最近公佈的季度虧損超出預期。</li>
<li><strong>Apple Inc.</strong> AAPL 的股票在盤前交易中下跌 1%，至 209.22 美元。蘋果公司正在進行重大管理重組。儘管公司面臨多年來最大的危機，首席執行官蒂姆·庫克仍然堅定掌舵。</li>
</ul>
</div><p><strong>Now Read This:</strong></p>
<div class="lb-trans"><p><strong>現在閲讀這個：</strong></p>
</div><ul>
<li><strong>Top 3 Real Estate Stocks That May Fall Off A Cliff This Month</strong></li>
</ul>
<div class="lb-trans"><ul>
<li><strong>本月可能會崩盤的前三隻房地產股票</strong></li>
</ul>
</div><p>Photo via Shutterstock</p>
<div class="lb-trans"><p>照片來源於 Shutterstock</p>
</div>

Ultragenyx Pharmaceutical, Apple And Other Big Stocks Moving Lower In Monday's Pre-Market Session

- 美國股指期貨今晨下跌，道瓊斯期貨下跌約 100 點。  
- Ultragenyx 製藥公司因 FDA 發出完整回應信，股價在盤前交易中下跌 8%。  
- 其他股票如 MiNK Therapeutics 和 Above Food 也在盤前交易中大幅下跌。  

Ultragenyx 製藥、蘋果及其他大型股票在週一盤前交易中股價下跌